Vanguard Group Inc Bridge Bio Pharma, Inc. Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 14,900,145 shares of BBIO stock, worth $510 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

14,900,145

Previous 15,077,915 1.18%

Holding current value

$510 Million

Previous $414 Million 24.5%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$28.12 - $37.59 $5 Million - $6.68 Million	-177,770 Reduced 1.18%	14,900,145 $515 Million
Q4 2024 Feb 11, 2025	BUY	$22.35 - $29.5 $19.6 Million - $25.9 Million	879,059 Added 6.19%	15,077,915 $414 Million
Q3 2024 Nov 13, 2024	BUY	$23.91 - $31.3 $3.45 Million - $4.51 Million	144,108 Added 1.03%	14,198,856 $362 Million
Q2 2024 Aug 13, 2024	BUY	$23.0 - $31.04 $19.2 Million - $25.8 Million	832,622 Added 6.3%	14,054,748 $356 Million
Q1 2024 May 10, 2024	BUY	$27.35 - $40.45 $11.5 Million - $17.1 Million	421,832 Added 3.3%	13,222,126 $409 Million
Q4 2023 Feb 14, 2024	BUY	$24.02 - $43.89 $36.6 Million - $66.9 Million	1,524,313 Added 13.52%	12,800,294 $517 Million
Q3 2023 Nov 14, 2023	SELL	$16.89 - $35.01 $6.91 Million - $14.3 Million	-409,016 Reduced 3.5%	11,275,981 $297 Million
Q2 2023 Aug 14, 2023	SELL	$13.29 - $18.01 $5.03 Million - $6.81 Million	-378,259 Reduced 3.14%	11,684,997 $201 Million
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $10.6 Million - $27.3 Million	1,471,801 Added 13.9%	12,063,256 $200 Million
Q4 2022 Feb 10, 2023	BUY	$6.74 - $11.52 $3.96 Million - $6.76 Million	587,184 Added 5.87%	10,591,455 $80.7 Million
Q3 2022 Nov 14, 2022	BUY	$7.94 - $12.36 $863,347 - $1.34 Million	108,734 Added 1.1%	10,004,271 $99.4 Million
Q2 2022 Aug 12, 2022	BUY	$5.21 - $12.14 $2.46 Million - $5.72 Million	471,425 Added 5.0%	9,895,537 $89.9 Million
Q1 2022 May 13, 2022	BUY	$7.34 - $17.16 $678,428 - $1.59 Million	92,429 Added 0.99%	9,424,112 $95.7 Million
Q4 2021 Feb 14, 2022	SELL	$11.38 - $53.41 $1.18 Million - $5.54 Million	-103,729 Reduced 1.1%	9,331,683 $156 Million
Q3 2021 Nov 12, 2021	SELL	$46.87 - $64.24 $88.8 Million - $122 Million	-1,893,717 Reduced 16.72%	9,435,412 $442 Million
Q2 2021 Aug 13, 2021	BUY	$46.47 - $63.93 $526 Million - $724 Million	11,329,129 New	11,329,129 $691 Million

Others Institutions Holding BBIO

# of Institutions

362

Shares Held

185M

Call Options Held

12.8M

Put Options Held

2.09M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $5.08B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Bridge Bio Pharma, Inc. Transaction History